Italy reviews diagnostics in Chikungunya alert
This article was originally published in Clinica
Executive Summary
Italy is reviewing its diagnostics capacity, in response to an outbreak of Chikungunya. Over the last two months, suspected cases have been rising - around 200 at September 6, according to the health ministry - and laboratory testing has so far confirmed the presence of the virus in at least 20% of cases. The outbreak is centred in the province of Ravenna, in the north of the country, where the Emilia Romagna regional health authority has been closely monitoring all potential cases since July.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.